SCOTTSDALE, Ariz., March 5, 2024 /PRNewswire/ -- Pinnacle Fertility, a leading network of high-performing family-building clinics, recently announced a strategic partnership with Labcorp (LH), a ...
BURLINGTON, N.C. and SAN FRANCISCO, May 7, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and Invitae (OTC:NVTAQ), a leading medical ...
Under the terms of the collaboration, LabCorp will be Vanda's exclusive commercialization partner for tests for genetic markers of the Fanapta (TM) program. "Working with innovative companies like ...
In February, the FDA approved the marketing of the first test to detect a genetic disorder known as Fragile X Syndrome or FXS. The test is designed for use in adults who may be potential carriers of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback